Literature DB >> 7676712

Technical aspects and complications of end-ileostomies.

E Carlsen1, A Bergan.   

Abstract

During a period of 10 years (1980-1990) we constructed or reconstructed 358 end-ileostomies: 224 were primary constructions, 96 were reconstructed by laparotomy, and 38 were local reconstruction. Only 2 ileostomies were primarily located on the left side. The mean length was 5 cm. We had 11.6% reoperations after primary stomy and 7.3% and 7.9% reoperations after reconstruction by laparotomy and local approach, respectively. There were 12.9% and 8.7% reoperations after emergency and elective primary operations, respectively. Closing the lateral gutter or fixation of ileum to the rectus fascia did not influence significantly the number of reoperations. Postoperative discolored stomy did not indicate more dysfunction of the ileostomy. Stenosis of the ileostomy, peristomal fistulas, and peristomal dermatitis were seen in 23 (10.3%), 21 (9.4%), and 18 (8%) of the patients after primary ileostomies, respectively. Patients with Crohn's disease had significantly more of these problems than patients with ulcerative colitis. Only a few patients had retraction of the ileostomy (2.7%), stomal prolapse (1.8%), or parastomal herniation (1.8%). Women had significantly more parastomal herniation than men; otherwise there were no differences between the sexes.

Entities:  

Mesh:

Year:  1995        PMID: 7676712     DOI: 10.1007/bf00294742

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  9 in total

1.  Parastomal hernias.

Authors:  R K Pearl
Journal:  World J Surg       Date:  1989 Sep-Oct       Impact factor: 3.352

2.  Indications and outcome of reoperation for ileostomy complications in inflammatory bowel disease.

Authors:  R M Weaver; J Alexander-Williams; M R Keighley
Journal:  Int J Colorectal Dis       Date:  1988-03       Impact factor: 2.571

3.  The management of an ileostomy, including its complications.

Authors:  B N BROOKE
Journal:  Lancet       Date:  1952-07-19       Impact factor: 79.321

Review 4.  Dermatologic complications in colostomy and ileostomy patients.

Authors:  J Hellman; C P Lago
Journal:  Int J Dermatol       Date:  1990-03       Impact factor: 2.736

5.  Long-term ileostomy complications in patients with ulcerative colitis and Crohn's disease.

Authors:  A Carlstedt; S Fasth; L Hultén; S Nordgren; I Palselius
Journal:  Int J Colorectal Dis       Date:  1987-02       Impact factor: 2.571

6.  Stomas.

Authors:  H Abcarian; R K Pearl
Journal:  Surg Clin North Am       Date:  1988-12       Impact factor: 2.741

7.  Demonstration of para-ileostomy herniation using computed tomography.

Authors:  R J Etherington; J G Williams; M W Hayward; L E Hughes
Journal:  Clin Radiol       Date:  1990-05       Impact factor: 2.350

8.  Periileostomy fistulae in Crohn's disease.

Authors:  A J Greenstein; A Dicker; S Meyers; A H Aufses
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

9.  Some factors influencing the outcome of stoma surgery.

Authors:  L P Leenen; J H Kuypers
Journal:  Dis Colon Rectum       Date:  1989-06       Impact factor: 4.585

  9 in total
  3 in total

Review 1.  Ileostomy diarrhea: Pathophysiology and management.

Authors:  Kyle M Rowe; Lawrence R Schiller
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-30

2.  Is An Ostomy Rod Useful for Bridging the Retraction During the Creation of a Loop Ileostomy? A Randomized Control Trial.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Toshihiro Bando; Teruhiro Chohno; Hirofumi Sasaki; Yuki Horio
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

3.  Elevated risk of stoma outlet obstruction following colorectal surgery in patients undergoing ileal pouch-anal anastomosis: a retrospective cohort study.

Authors:  Satoshi Okada; Keisuke Hata; Shigenobu Emoto; Koji Murono; Manabu Kaneko; Kazuhito Sasaki; Kensuke Otani; Takeshi Nishikawa; Toshiaki Tanaka; Kazushige Kawai; Hiroaki Nozawa
Journal:  Surg Today       Date:  2018-07-25       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.